Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn
- 2 April 1999
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 38 (5) , 611-623
- https://doi.org/10.1016/s0028-3908(98)00218-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonistBritish Journal of Pharmacology, 1997
- Modulation of 45Ca2+ Influx into Cells Stably Expressing Recombinant Human NMDA Receptors by Ligands Acting at Distinct Recognition SitesJournal of Neurochemistry, 1996
- Lamotrigine control of idiopathic trigeminal neuralgia.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brainNeuroReport, 1995
- Intravenous Infusion of the NMDA Antagonist, Ketamine, in Chronic Posttraumatic Pain with AllodyniaClinical Neuropharmacology, 1995
- Continuous subcutaneous administration of the N -methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgiaPain, 1995
- The Symbol receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in manPain, 1994
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983